Side effects have never been separated out according to what disorder the physician prescribed the medicine, as far as I’ve ever seen in the kind of monograph that’s enclosed in prescrption packages or attached to them by drugstores. But that kind of correlation could be quite important. If it isn’t fibromyalgia patients who are at significant risk here, that points a finger at latent mental health problems in mental health disorder sufferers.
I know from experience that the side effects don’t discriminate (whether you are a nerve pain patient being prescribed meds for off label use, or are getting on label use prescription for mental issues). That doesn’t mean there isn’t / wasn’t some undiagnosed latent mental predisposition of higher risk for nerve pain sufferers, but it is suspicious.
There are serious faults with the FDA reporting system and the database made from it. MAUDE is a good example of that.